0AAU logo

Surgical Science Sweden LSE:0AAU Stock Report

Last Price

kr154.10

Market Cap

kr7.9b

7D

1.9%

1Y

-17.6%

Updated

29 Apr, 2024

Data

Company Financials +

Surgical Science Sweden AB (publ)

LSE:0AAU Stock Report

Market Cap: kr7.9b

0AAU Stock Overview

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally.

0AAU fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance4/6
Financial Health6/6
Dividends0/6

Surgical Science Sweden AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Surgical Science Sweden
Historical stock prices
Current Share Pricekr154.10
52 Week Highkr264.80
52 Week Lowkr119.50
Beta0.93
1 Month Change1.58%
3 Month Change-15.50%
1 Year Change-17.63%
3 Year Changen/a
5 Year Changen/a
Change since IPO-8.84%

Recent News & Updates

Recent updates

Shareholder Returns

0AAUGB Medical EquipmentGB Market
7D1.9%-2.8%1.4%
1Y-17.6%-13.9%1.1%

Return vs Industry: 0AAU underperformed the UK Medical Equipment industry which returned -13.9% over the past year.

Return vs Market: 0AAU underperformed the UK Market which returned 1.1% over the past year.

Price Volatility

Is 0AAU's price volatile compared to industry and market?
0AAU volatility
0AAU Average Weekly Movement6.7%
Medical Equipment Industry Average Movement7.4%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.7%

Stable Share Price: 0AAU has not had significant price volatility in the past 3 months.

Volatility Over Time: 0AAU's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997260Gisli Hennermarkwww.surgicalscience.com

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room.

Surgical Science Sweden AB (publ) Fundamentals Summary

How do Surgical Science Sweden's earnings and revenue compare to its market cap?
0AAU fundamental statistics
Market capkr7.94b
Earnings (TTM)kr233.97m
Revenue (TTM)kr882.85m

33.9x

P/E Ratio

9.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0AAU income statement (TTM)
Revenuekr882.85m
Cost of Revenuekr269.97m
Gross Profitkr612.88m
Other Expenseskr378.91m
Earningskr233.97m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 15, 2024

Earnings per share (EPS)4.59
Gross Margin69.42%
Net Profit Margin26.50%
Debt/Equity Ratio0%

How did 0AAU perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.